-
Lifeist Portfolio Co. Mikra Launches Presales Of CELLF To Help Combat Fatigue, Inflammation & Brain Fog
Wednesday, March 9, 2022 - 10:48am | 407Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTC: NXTTF) announced several business updates regarding its wholly owned U.S. subsidiary, Mikra, Cellular Sciences Inc., including the commencement of presales in the U.S. for its novel cellular therapeutic compound, CELLF, targeted at combating...
-
Can Cannabis Help You Lose Weight? Marijuana Lowers BMI & Fights Inflammation, New Study Reveals
Thursday, March 3, 2022 - 2:39pm | 449Cannabis has long been known for its anti-inflammatory properties. Obesity - now a global issue - is associated with changes in immunity resulting in chronic inflammation in the human body. A study published in the Archives of Medical Science characterizes obesity as the accumulation of abnormal or...
-
Inflammation And Marijuana - What's The Relationship Between Cannabis And Swelling Relief?
Friday, February 11, 2022 - 1:00pm | 1203This article was originally published on Cannabis.net and appears here with permission. Regardless of how anyone feels about inflammation or the amount of pain it comes with, it remains an unavoidable healthy response that keeps us alive. From bruising a finger to the after-effects of cancer...
-
Landos Biopharma Stock Is Trading Higher On Initiating Early-Stage Study With Omilancor For Esophagus Inflammation
Tuesday, April 6, 2021 - 9:53am | 304The FDA has signed off Landos Biopharma's (NASDAQ: LABP) Investigational New Drug application for omilancor (BT-11) for the treatment of Eosinophilic Esophagitis (EoE). Landos expects to initiate patient dosing in the first half of 2022. The 36-subject Phase 1b study is...
-
Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY)
Tuesday, July 16, 2013 - 11:30am | 536Eli Lilly & Co. (NYSE: LLY) planned to go back to the drawing board with its new experimental Alzheimer’s drug, according Bloomberg. The drug, solanezumab, which was not successful with advanced Alzheimer’s patients, will be tested in patients who show signs of early stages of the disease...